HEB - Hemispherx Biopharma, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate-1.71-1.46-7.14-4.46
Low Estimate-1.76-1.76-7.48-6.6
High Estimate-1.67-1.17-6.8-2.32
Year Ago EPS-3.08-1.32-9.68-7.14
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate70k200k330k420k
Low Estimate70k90k240k240k
High Estimate80k300k430k600k
Year Ago SalesN/A240k367k330k
Sales Growth (year/est)N/A-16.70%-10.10%27.30%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-2.64-3.08-2.2-1.7
EPS Actual-3.08-1.32-3.08-1.07
Difference-0.441.76-0.880.63
Surprise %-16.70%57.10%-40.00%37.10%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.71-1.46-7.14-4.46
7 Days Ago-1.71-1.46-7.14-4.46
30 Days Ago-1.71-1.46-7.14-4.46
60 Days Ago-0.04-0.04-0.17-0.15
90 Days Ago-0.05-0.05-0.2-0.2
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesHEBIndustrySectorS&P 500
Current Qtr.44.50%N/AN/A-0.00
Next Qtr.-10.60%N/AN/A0.08
Current Year26.20%N/AN/A0.03
Next Year37.50%N/AN/A0.10
Next 5 Years (per annum)25.00%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A